Conversations from CROI 2015: Dr. Laura Cheever

Content From: Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human ServicesPublished: February 27, 20151 min read

Topics

Colleagues from HRSA last week that demonstrated the effectiveness of the Ryan White HIV/AIDS Program. We had the opportunity to discuss these research findings with Dr. Laura Cheever, HRSA’s Associate Administrator for the HIV/AIDS Bureau, which manages the Ryan White HIV/AIDS Program (RWHAP). She provided us with an overview of the poster presented at the conference of HIV and other infectious disease researchers held in Seattle last week.

 

 

croi2015_w280x100

The poster was titled “Impact of the Ryan White HIV/AIDS Program on HIV Treatment Outcomes in the U.S” . It presents analysis of data from CDC’s Medical Monitoring Project from 2009-2012 to assess the association between receiving RWHAP assistance, alone or in combination with other sources of healthcare coverage, and HIV treatment outcomes among HIV-infected adults in medical care.

As Dr. Cheever explains in this video interview, the analysis found that uninsured and under-insured persons living with HIV infection who received RWHAP assistance were more likely to be prescribed ART and be virally suppressed than those with many other healthcare payer types.